Drug – Share Talk

Midatech Pharma PLC (MTPH.L) Headline Results of MTX110 Phase I DIPG Study

abm October 19, 2020

Phase II Dose Confirmed and Encouraging Survival Data

TPI provides its latest research note on Midatech Pharma plc (MTPH.L).

abm October 19, 2020

Midatech has today announced encouraging headline results from a Phase I study at the University of California, San Francisco (‘UCSF’) in patients with the orphan condition, Diffuse Intrinsic Pontine Glioma

TPI provides its latest research note on Midatech Pharma plc (MTPH.L)

abm September 10, 2020

Midatech has announced unaudited interim results for the six months ended 30 June 2020. These cover a period of significant transition for the Group, subsequent to which it has raised

Sareum Holdings PLC (SAR.L) Research Update

abm July 24, 2020

Encouraging Preclinical Results Generated with Sareum’s TYK2/JAK1 Inhibitors in a Disease Model of Lupus

Evgen Pharma PLC (EVG.L) SFX-01 to be evaluated in COVID-19 trial

abm June 17, 2020

Evgen Pharma plc (AIM: EVG), the clinical stage drug development company, is delighted to announce participation in the recently notified funding initiative for COVID-19 clinical trials by the medical research

Evgen Pharma (EVG.L) Clinical trial that could reduce Covid-19 deaths

abm June 16, 2020

The University of Dundee is leading the clinical trial of a new anti-inflammatory drug it is hoped may reduce instances of severe lung damage and death in Covid-19 patients.

TPI provides its latest research note on Midatech Pharma plc (MTPH.L).

abm June 8, 2020

Midatech has announced it has entered into a research collaboration with Dr Reddy’s Laboratories (BSE:500124, NSE:DRREDDY, NYSE:RDY) (‘Dr. Reddy’s), the global pharmaceutical company.

Overview facts about hVIVO COVID Clear & FAQ

abm June 6, 2020

Open Orphan is a rapidly growing niche CRO pharmaceutical services company which is a world leader in the testing of vaccines and antivirals through the use of human challenge clinical